How is oral isotretinoin prescribed for the treatment of acne vulgaris? Results from a UK Dermatology Clinical Trials Network (UKDCTN) and British Dermatological Nursing Group (BDNG) survey of health professionals
How is oral isotretinoin prescribed for the treatment of acne vulgaris? Results from a UK Dermatology Clinical Trials Network (UKDCTN) and British Dermatological Nursing Group (BDNG) survey of health professionals
We undertook a survey of UK healthcare professionals through the UKDCTN and BDNG to understand clinicians’ routine practice prescribing oral isotretinoin for treatment of acne vulgaris (acne). We also wanted to understand clinicians’ experiences and views on prescribing low daily dose regimens. Overall, the survey showed that clinicians adopted a patient-centred approach when deciding isotretinoin dosing. The rationale for using a low-dose regimen varied, but was focused on patient wellbeing during treatment. Some clinicians were concerned that use of a low-dose regimen could be less effective and lead to longer treatment durations. The survey results will be useful to inform a clinical trial investigating the effectiveness and safety of low daily dose isotretinoin for the treatment of acne.
Moledina, Zahra
fde6d28d-5ed5-4351-a7a5-aa00b1470657
McPhee, Margaret
77faabbb-7dc6-4c5f-8bd6-26401eadb8f5
Ravenscroft, Jane
c04b5faa-bcd0-4d5d-a5ff-44b3342e4ced
Radley, Kathy
870ce00b-0f91-48cd-a787-22e6476ccdf5
Thomas, Kim S
a1fb9576-e4e3-4829-ac19-3dd1b3938557
Burden-Teh, Esther
4b1ee272-e52e-40dc-b517-cdaa9dac233b
20 October 2022
Moledina, Zahra
fde6d28d-5ed5-4351-a7a5-aa00b1470657
McPhee, Margaret
77faabbb-7dc6-4c5f-8bd6-26401eadb8f5
Ravenscroft, Jane
c04b5faa-bcd0-4d5d-a5ff-44b3342e4ced
Radley, Kathy
870ce00b-0f91-48cd-a787-22e6476ccdf5
Thomas, Kim S
a1fb9576-e4e3-4829-ac19-3dd1b3938557
Burden-Teh, Esther
4b1ee272-e52e-40dc-b517-cdaa9dac233b
Moledina, Zahra, McPhee, Margaret, Ravenscroft, Jane, Healy, Eugene, Radley, Kathy, Thomas, Kim S and Burden-Teh, Esther
(2022)
How is oral isotretinoin prescribed for the treatment of acne vulgaris? Results from a UK Dermatology Clinical Trials Network (UKDCTN) and British Dermatological Nursing Group (BDNG) survey of health professionals.
Clinical and Experimental Dermatology.
(doi:10.1093/ced/llac015).
Abstract
We undertook a survey of UK healthcare professionals through the UKDCTN and BDNG to understand clinicians’ routine practice prescribing oral isotretinoin for treatment of acne vulgaris (acne). We also wanted to understand clinicians’ experiences and views on prescribing low daily dose regimens. Overall, the survey showed that clinicians adopted a patient-centred approach when deciding isotretinoin dosing. The rationale for using a low-dose regimen varied, but was focused on patient wellbeing during treatment. Some clinicians were concerned that use of a low-dose regimen could be less effective and lead to longer treatment durations. The survey results will be useful to inform a clinical trial investigating the effectiveness and safety of low daily dose isotretinoin for the treatment of acne.
Text
How is isotretinoin prescribed for the treatment of acne vulgaris - Revised MANUSCRIPT_clean copy
- Accepted Manuscript
Restricted to Repository staff only until 20 October 2023.
More information
Accepted/In Press date: 15 September 2022
Published date: 20 October 2022
Additional Information:
Dermatology output
Identifiers
Local EPrints ID: 471567
URI: http://eprints.soton.ac.uk/id/eprint/471567
ISSN: 0307-6938
PURE UUID: 0821da0e-d4f9-43f8-982c-4ab425c790a2
Catalogue record
Date deposited: 11 Nov 2022 17:41
Last modified: 11 Nov 2022 17:41
Export record
Altmetrics
Contributors
Author:
Zahra Moledina
Author:
Margaret McPhee
Author:
Jane Ravenscroft
Author:
Eugene Healy
Author:
Kathy Radley
Author:
Kim S Thomas
Author:
Esther Burden-Teh
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics